BlackRock
CAMP icon

BlackRock’s CAMP4 Therapeutics CAMP Stock Holding History

BlackRock’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.18M Buy
1,644,134
+1,187,763
+260% +$5.12M ﹤0.01% 3813
2026
Q1 		$2.01M Buy
456,371
+66,211
+17% +$314K ﹤0.01% 4134
2025
Q4 		$2.39M Buy
390,160
+378,723
+3,311% +$1.61M ﹤0.01% 4069
2025
Q3 		$34.3K Sell
11,437
-72,784
-86% -$135K ﹤0.01% 5046
2025
Q2 		$122K Sell
84,221
-211,995
-72% -$422K ﹤0.01% 4793
2025
Q1 		$1.18M Buy
296,216
+30,846
+12% +$149K ﹤0.01% 4147
2024
Q4 		$1.39M Buy
+265,370
New +$2.18M ﹤0.01% 4139

Other funds holding CAMP

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock's CAMP Position: Q2 2026 in Review

BlackRock increased its CAMP4 Therapeutics (CAMP) stake by 260% in Q2 2026, buying an estimated $5.12M and bringing the position to 1,644,134 shares worth $7.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3813.

BlackRock first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. 16 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • BlackRock held 1,644,134 shares of CAMP4 Therapeutics worth $7.18M as of Q2 2026.
  • BlackRock bought 1,187,763 CAMP4 Therapeutics shares in Q2 2026, an estimated $5.12M.
  • CAMP4 Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3813 holding.
  • BlackRock first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 16 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.